avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSMUSG00000030067.11 | forkhead box P1 |
Foxj2
|
ENSMUSG00000003154.9 | forkhead box J2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp1 | mm10_v2_chr6_-_99028251_99028313 | -0.57 | 2.6e-04 | Click! |
Foxj2 | mm10_v2_chr6_+_122819888_122819938 | -0.51 | 1.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_81975742 | 28.77 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr6_+_122006798 | 24.05 |
ENSMUST00000081777.6
|
Mug2
|
murinoglobulin 2 |
chr1_-_139781236 | 22.29 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr1_-_130661584 | 19.87 |
ENSMUST00000137276.2
|
C4bp
|
complement component 4 binding protein |
chr1_-_130661613 | 19.51 |
ENSMUST00000027657.7
|
C4bp
|
complement component 4 binding protein |
chr2_+_68117713 | 19.26 |
ENSMUST00000112346.2
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr5_-_145879857 | 19.25 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr12_-_104153846 | 18.77 |
ENSMUST00000085050.3
|
Serpina3c
|
serine (or cysteine) peptidase inhibitor, clade A, member 3C |
chr19_-_39463067 | 17.20 |
ENSMUST00000035488.2
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr10_+_127898515 | 16.76 |
ENSMUST00000047134.7
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr1_-_139608282 | 16.28 |
ENSMUST00000170441.2
|
Cfhr3
|
complement factor H-related 3 |
chr18_-_3281036 | 15.81 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr14_-_51913393 | 15.06 |
ENSMUST00000004673.7
ENSMUST00000111632.3 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chrX_+_139800795 | 13.91 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr10_-_41611319 | 13.61 |
ENSMUST00000179614.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr7_-_119523477 | 13.26 |
ENSMUST00000033267.2
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr17_-_12675833 | 13.23 |
ENSMUST00000024596.8
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr15_-_78468620 | 12.83 |
ENSMUST00000017086.3
|
Tmprss6
|
transmembrane serine protease 6 |
chr17_-_46438471 | 12.74 |
ENSMUST00000087012.5
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr14_+_55560480 | 12.59 |
ENSMUST00000121622.1
ENSMUST00000143431.1 ENSMUST00000150481.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr8_-_84773381 | 12.58 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr11_-_113708952 | 12.16 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr1_-_193241424 | 12.06 |
ENSMUST00000162842.1
ENSMUST00000160929.1 |
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr3_+_138415484 | 11.79 |
ENSMUST00000161312.1
ENSMUST00000013458.8 |
Adh4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr1_-_162898665 | 11.74 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr19_+_30232921 | 11.57 |
ENSMUST00000025797.5
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr5_+_90561102 | 11.44 |
ENSMUST00000094615.4
|
5830473C10Rik
|
RIKEN cDNA 5830473C10 gene |
chr5_-_87254804 | 11.39 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr4_+_133553370 | 11.32 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr6_+_121346618 | 11.24 |
ENSMUST00000032200.9
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr6_-_138079916 | 11.03 |
ENSMUST00000171804.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr8_+_36457548 | 10.98 |
ENSMUST00000135373.1
ENSMUST00000147525.1 |
6430573F11Rik
|
RIKEN cDNA 6430573F11 gene |
chr2_+_58755177 | 10.97 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr14_+_55561060 | 10.85 |
ENSMUST00000117701.1
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr14_+_55560904 | 10.80 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr2_+_58754910 | 10.73 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr15_+_6445320 | 10.71 |
ENSMUST00000022749.9
|
C9
|
complement component 9 |
chr10_+_93488766 | 10.59 |
ENSMUST00000129421.1
|
Hal
|
histidine ammonia lyase |
chr8_-_121944886 | 10.53 |
ENSMUST00000057653.7
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr6_+_121838514 | 10.52 |
ENSMUST00000032228.8
|
Mug1
|
murinoglobulin 1 |
chrX_-_7681034 | 10.43 |
ENSMUST00000115695.3
|
Magix
|
MAGI family member, X-linked |
chr9_-_48605147 | 10.23 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_+_63295815 | 10.15 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr15_+_25940846 | 10.10 |
ENSMUST00000110438.1
|
Fam134b
|
family with sequence similarity 134, member B |
chr4_+_60838256 | 9.76 |
ENSMUST00000098035.4
|
Gm21286
|
predicted gene, 21286 |
chr15_-_58214882 | 9.64 |
ENSMUST00000022986.6
|
Fbxo32
|
F-box protein 32 |
chr1_+_130865669 | 9.47 |
ENSMUST00000038829.5
|
Faim3
|
Fas apoptotic inhibitory molecule 3 |
chr11_-_46389509 | 9.45 |
ENSMUST00000020664.6
|
Itk
|
IL2 inducible T cell kinase |
chr2_+_4718145 | 9.36 |
ENSMUST00000056914.6
|
Bend7
|
BEN domain containing 7 |
chr6_-_124911636 | 9.26 |
ENSMUST00000032217.1
|
Lag3
|
lymphocyte-activation gene 3 |
chr11_-_46389471 | 9.25 |
ENSMUST00000109237.2
|
Itk
|
IL2 inducible T cell kinase |
chr18_-_38918642 | 9.19 |
ENSMUST00000040647.4
|
Fgf1
|
fibroblast growth factor 1 |
chr11_+_70054334 | 9.05 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr10_+_128254131 | 9.01 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr11_-_86993682 | 9.00 |
ENSMUST00000018571.4
|
Ypel2
|
yippee-like 2 (Drosophila) |
chr15_+_99392882 | 8.94 |
ENSMUST00000023749.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr19_+_5406815 | 8.94 |
ENSMUST00000174412.1
ENSMUST00000153017.2 |
4930481A15Rik
|
RIKEN cDNA 4930481A15 gene |
chr7_+_140763739 | 8.93 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr17_+_36942910 | 8.92 |
ENSMUST00000040498.5
|
Rnf39
|
ring finger protein 39 |
chr15_-_60921270 | 8.90 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr19_-_34879452 | 8.67 |
ENSMUST00000036584.5
|
Pank1
|
pantothenate kinase 1 |
chr8_+_105269788 | 8.66 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr18_-_61536522 | 8.65 |
ENSMUST00000171629.1
|
Arhgef37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr5_-_87569023 | 8.62 |
ENSMUST00000113314.2
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr18_+_51117754 | 8.54 |
ENSMUST00000116639.2
|
Prr16
|
proline rich 16 |
chr12_-_103657159 | 8.49 |
ENSMUST00000044159.6
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr5_-_87091150 | 8.39 |
ENSMUST00000154455.1
|
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr1_+_167618246 | 8.32 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr15_+_3270767 | 8.30 |
ENSMUST00000082424.4
ENSMUST00000159158.1 ENSMUST00000159216.1 ENSMUST00000160311.1 |
Sepp1
|
selenoprotein P, plasma, 1 |
chr2_-_110314525 | 8.10 |
ENSMUST00000133608.1
|
Bbox1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
chr17_+_12584183 | 8.06 |
ENSMUST00000046959.7
|
Slc22a2
|
solute carrier family 22 (organic cation transporter), member 2 |
chr15_-_5063741 | 8.06 |
ENSMUST00000110689.3
|
C7
|
complement component 7 |
chr1_-_72212249 | 8.05 |
ENSMUST00000048860.7
|
Mreg
|
melanoregulin |
chr15_+_99393219 | 7.92 |
ENSMUST00000159209.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr7_-_133782721 | 7.91 |
ENSMUST00000063669.1
|
Dhx32
|
DEAH (Asp-Glu-Ala-His) box polypeptide 32 |
chr15_+_99392948 | 7.86 |
ENSMUST00000161250.1
ENSMUST00000160635.1 ENSMUST00000161778.1 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr17_-_34743849 | 7.85 |
ENSMUST00000069507.8
|
C4b
|
complement component 4B (Chido blood group) |
chr12_-_84450944 | 7.84 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr17_+_36943025 | 7.77 |
ENSMUST00000173072.1
|
Rnf39
|
ring finger protein 39 |
chr11_+_114851142 | 7.73 |
ENSMUST00000133245.1
ENSMUST00000122967.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr12_-_84400929 | 7.70 |
ENSMUST00000122194.1
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr9_+_7445822 | 7.68 |
ENSMUST00000034497.6
|
Mmp3
|
matrix metallopeptidase 3 |
chr19_-_7802578 | 7.64 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr4_-_104876383 | 7.56 |
ENSMUST00000064873.8
ENSMUST00000106808.3 ENSMUST00000048947.8 |
C8a
|
complement component 8, alpha polypeptide |
chr5_+_146079254 | 7.55 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chrX_+_7722267 | 7.46 |
ENSMUST00000125991.1
ENSMUST00000148624.1 |
Wdr45
|
WD repeat domain 45 |
chr14_-_55560340 | 7.45 |
ENSMUST00000066106.3
|
A730061H03Rik
|
RIKEN cDNA A730061H03 gene |
chr9_+_50494516 | 7.43 |
ENSMUST00000114474.1
|
1600029D21Rik
|
RIKEN cDNA 1600029D21 gene |
chr4_-_6275629 | 7.38 |
ENSMUST00000029905.1
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr16_+_91269759 | 7.28 |
ENSMUST00000056882.5
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr10_+_87859481 | 7.26 |
ENSMUST00000121952.1
|
Igf1
|
insulin-like growth factor 1 |
chr10_+_87859593 | 7.20 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr11_-_46389454 | 7.16 |
ENSMUST00000101306.3
|
Itk
|
IL2 inducible T cell kinase |
chrX_-_139782353 | 7.16 |
ENSMUST00000101217.3
|
Ripply1
|
ripply1 homolog (zebrafish) |
chr16_+_22920222 | 7.14 |
ENSMUST00000023587.4
ENSMUST00000116625.2 |
Fetub
|
fetuin beta |
chr1_-_179546261 | 6.99 |
ENSMUST00000027769.5
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr3_+_107230608 | 6.98 |
ENSMUST00000179399.1
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr2_-_58052832 | 6.94 |
ENSMUST00000090940.5
|
Ermn
|
ermin, ERM-like protein |
chr10_+_111506286 | 6.89 |
ENSMUST00000164773.1
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1 |
chr4_+_45012830 | 6.82 |
ENSMUST00000095105.1
|
1700055D18Rik
|
RIKEN cDNA 1700055D18 gene |
chr3_+_138374121 | 6.81 |
ENSMUST00000171054.1
|
Adh6-ps1
|
alcohol dehydrogenase 6 (class V), pseudogene 1 |
chr4_-_96664112 | 6.80 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr5_-_105239533 | 6.78 |
ENSMUST00000065588.6
|
Gbp10
|
guanylate-binding protein 10 |
chrX_+_7722214 | 6.76 |
ENSMUST00000043045.2
ENSMUST00000116634.1 ENSMUST00000115689.3 ENSMUST00000131077.1 ENSMUST00000115688.1 ENSMUST00000116633.1 |
Wdr45
|
WD repeat domain 45 |
chr8_-_93337195 | 6.70 |
ENSMUST00000044602.7
|
Ces1g
|
carboxylesterase 1G |
chr1_+_88103229 | 6.69 |
ENSMUST00000113135.3
ENSMUST00000113138.1 |
Ugt1a6a
Ugt1a6b
|
UDP glucuronosyltransferase 1 family, polypeptide A6A UDP glucuronosyltransferase 1 family, polypeptide A6B |
chr8_+_45658666 | 6.57 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr12_-_103657095 | 6.54 |
ENSMUST00000152517.1
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr13_+_4191163 | 6.49 |
ENSMUST00000021634.2
|
Akr1c13
|
aldo-keto reductase family 1, member C13 |
chr4_-_96591555 | 6.46 |
ENSMUST00000055693.8
|
Cyp2j9
|
cytochrome P450, family 2, subfamily j, polypeptide 9 |
chr9_+_55326913 | 6.46 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr12_-_103904887 | 6.42 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr12_-_103773592 | 6.29 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr3_+_146597077 | 6.28 |
ENSMUST00000029837.7
ENSMUST00000121133.1 |
Uox
|
urate oxidase |
chr2_+_43555342 | 6.25 |
ENSMUST00000112826.1
ENSMUST00000050511.6 |
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr13_+_89540636 | 6.21 |
ENSMUST00000022108.7
|
Hapln1
|
hyaluronan and proteoglycan link protein 1 |
chr1_+_93990509 | 6.19 |
ENSMUST00000097632.3
|
Gm6086
|
predicted gene 6086 |
chr16_+_20097554 | 6.17 |
ENSMUST00000023509.3
|
Klhl24
|
kelch-like 24 |
chr14_-_45477856 | 6.17 |
ENSMUST00000141424.1
|
Fermt2
|
fermitin family homolog 2 (Drosophila) |
chr2_-_65364000 | 6.14 |
ENSMUST00000155962.1
ENSMUST00000112420.1 ENSMUST00000152324.1 |
Slc38a11
|
solute carrier family 38, member 11 |
chr10_-_89533550 | 6.06 |
ENSMUST00000105297.1
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr3_-_146596588 | 6.01 |
ENSMUST00000029836.4
|
Dnase2b
|
deoxyribonuclease II beta |
chr14_+_55559993 | 5.98 |
ENSMUST00000117236.1
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr10_+_84838143 | 5.95 |
ENSMUST00000095388.4
|
Rfx4
|
regulatory factor X, 4 (influences HLA class II expression) |
chr5_-_34187670 | 5.94 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr7_-_90129339 | 5.94 |
ENSMUST00000181189.1
|
2310010J17Rik
|
RIKEN cDNA 2310010J17 gene |
chr19_+_23141183 | 5.90 |
ENSMUST00000036884.1
|
Klf9
|
Kruppel-like factor 9 |
chr11_+_119022962 | 5.89 |
ENSMUST00000026662.7
|
Cbx2
|
chromobox 2 |
chr9_+_53301571 | 5.88 |
ENSMUST00000051014.1
|
Exph5
|
exophilin 5 |
chr1_+_87574016 | 5.85 |
ENSMUST00000166259.1
ENSMUST00000172222.1 ENSMUST00000163606.1 |
Neu2
|
neuraminidase 2 |
chr19_-_8218832 | 5.84 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr14_-_31640878 | 5.84 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chrX_-_100412587 | 5.83 |
ENSMUST00000033567.8
|
Awat2
|
acyl-CoA wax alcohol acyltransferase 2 |
chr18_-_6136057 | 5.77 |
ENSMUST00000182559.1
|
Arhgap12
|
Rho GTPase activating protein 12 |
chr13_+_4434306 | 5.71 |
ENSMUST00000021630.8
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr9_+_74976096 | 5.69 |
ENSMUST00000081746.5
|
Fam214a
|
family with sequence similarity 214, member A |
chr15_-_97020322 | 5.66 |
ENSMUST00000166223.1
|
Slc38a4
|
solute carrier family 38, member 4 |
chr2_-_148040196 | 5.64 |
ENSMUST00000136555.1
|
9030622O22Rik
|
RIKEN cDNA 9030622O22 gene |
chr6_-_71440623 | 5.64 |
ENSMUST00000002292.8
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr10_-_107123585 | 5.64 |
ENSMUST00000165067.1
ENSMUST00000044668.4 |
Acss3
|
acyl-CoA synthetase short-chain family member 3 |
chr17_+_31433054 | 5.53 |
ENSMUST00000136384.1
|
Pde9a
|
phosphodiesterase 9A |
chr5_+_92331828 | 5.53 |
ENSMUST00000125462.1
ENSMUST00000121096.1 ENSMUST00000113083.2 |
Art3
|
ADP-ribosyltransferase 3 |
chr3_+_81996922 | 5.50 |
ENSMUST00000029641.3
|
Asic5
|
acid-sensing (proton-gated) ion channel family member 5 |
chr1_+_106171752 | 5.50 |
ENSMUST00000061047.6
|
Phlpp1
|
PH domain and leucine rich repeat protein phosphatase 1 |
chr9_-_45955226 | 5.50 |
ENSMUST00000038488.9
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr9_-_121916288 | 5.47 |
ENSMUST00000062474.4
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr19_+_5877794 | 5.47 |
ENSMUST00000145200.1
ENSMUST00000025732.7 ENSMUST00000125114.1 ENSMUST00000155697.1 |
Slc25a45
|
solute carrier family 25, member 45 |
chr18_+_45268876 | 5.45 |
ENSMUST00000183850.1
ENSMUST00000066890.7 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr10_+_87859255 | 5.41 |
ENSMUST00000105300.2
|
Igf1
|
insulin-like growth factor 1 |
chr8_-_95434869 | 5.40 |
ENSMUST00000034249.6
|
Gtl3
|
gene trap locus 3 |
chr11_+_118433826 | 5.39 |
ENSMUST00000106286.1
|
C1qtnf1
|
C1q and tumor necrosis factor related protein 1 |
chr10_+_87860030 | 5.38 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr9_-_45955170 | 5.37 |
ENSMUST00000162072.1
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr6_-_59024470 | 5.32 |
ENSMUST00000089860.5
|
Fam13a
|
family with sequence similarity 13, member A |
chr2_+_28641227 | 5.30 |
ENSMUST00000028155.5
ENSMUST00000113869.1 ENSMUST00000113867.2 |
Tsc1
|
tuberous sclerosis 1 |
chr11_-_54860564 | 5.30 |
ENSMUST00000144164.1
|
Lyrm7
|
LYR motif containing 7 |
chr4_+_104913456 | 5.24 |
ENSMUST00000106803.2
ENSMUST00000106804.1 |
1700024P16Rik
|
RIKEN cDNA 1700024P16 gene |
chr2_+_34874396 | 5.23 |
ENSMUST00000113068.2
ENSMUST00000047447.8 |
Cutal
|
cutA divalent cation tolerance homolog-like |
chr5_+_30921825 | 5.22 |
ENSMUST00000117435.1
|
Khk
|
ketohexokinase |
chr2_-_64975762 | 5.20 |
ENSMUST00000156765.1
|
Grb14
|
growth factor receptor bound protein 14 |
chr5_+_92331818 | 5.15 |
ENSMUST00000154245.1
|
Art3
|
ADP-ribosyltransferase 3 |
chr19_+_4855129 | 5.14 |
ENSMUST00000119694.1
|
Ctsf
|
cathepsin F |
chr1_+_171225054 | 5.14 |
ENSMUST00000111321.1
ENSMUST00000005824.5 ENSMUST00000111320.1 ENSMUST00000111319.1 |
Apoa2
|
apolipoprotein A-II |
chr10_+_87859062 | 5.14 |
ENSMUST00000095360.4
|
Igf1
|
insulin-like growth factor 1 |
chr19_+_26750939 | 5.11 |
ENSMUST00000175953.1
|
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr1_-_139560158 | 5.09 |
ENSMUST00000160423.1
ENSMUST00000023965.5 |
Cfhr1
|
complement factor H-related 1 |
chr3_+_94362444 | 5.04 |
ENSMUST00000169433.1
|
C2cd4d
|
C2 calcium-dependent domain containing 4D |
chr6_+_134830145 | 5.04 |
ENSMUST00000046303.5
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr5_-_87424201 | 5.03 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr1_+_67123015 | 5.01 |
ENSMUST00000027144.7
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr12_-_84400851 | 4.99 |
ENSMUST00000117286.1
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr10_-_18234930 | 4.98 |
ENSMUST00000052648.8
ENSMUST00000080860.6 ENSMUST00000173243.1 |
Ccdc28a
|
coiled-coil domain containing 28A |
chr4_+_97777606 | 4.95 |
ENSMUST00000075448.6
ENSMUST00000092532.6 |
Nfia
|
nuclear factor I/A |
chr2_-_160872985 | 4.94 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr16_+_43508118 | 4.93 |
ENSMUST00000114690.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr6_+_124916863 | 4.89 |
ENSMUST00000069553.2
|
A230083G16Rik
|
RIKEN cDNA A230083G16 gene |
chr9_+_119402444 | 4.87 |
ENSMUST00000035093.8
ENSMUST00000165044.1 |
Acvr2b
|
activin receptor IIB |
chr2_+_34874486 | 4.83 |
ENSMUST00000028228.3
|
Cutal
|
cutA divalent cation tolerance homolog-like |
chr9_-_45954966 | 4.73 |
ENSMUST00000114573.2
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr2_+_126556128 | 4.69 |
ENSMUST00000141482.2
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr5_+_139389785 | 4.68 |
ENSMUST00000100514.2
|
Gpr146
|
G protein-coupled receptor 146 |
chr4_+_144893077 | 4.68 |
ENSMUST00000154208.1
|
Dhrs3
|
dehydrogenase/reductase (SDR family) member 3 |
chr6_+_134830216 | 4.67 |
ENSMUST00000111937.1
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr9_+_46268601 | 4.62 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr5_+_92386879 | 4.61 |
ENSMUST00000128246.1
|
Art3
|
ADP-ribosyltransferase 3 |
chr7_-_25390098 | 4.58 |
ENSMUST00000054301.7
|
Lipe
|
lipase, hormone sensitive |
chr16_+_43235856 | 4.58 |
ENSMUST00000146708.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr10_+_60106452 | 4.56 |
ENSMUST00000165024.2
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr6_-_142322978 | 4.56 |
ENSMUST00000081380.3
|
Slco1a5
|
solute carrier organic anion transporter family, member 1a5 |
chr1_-_180195981 | 4.56 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr12_-_85270564 | 4.49 |
ENSMUST00000019378.6
ENSMUST00000166821.1 |
Mlh3
|
mutL homolog 3 (E coli) |
chr11_+_70214105 | 4.46 |
ENSMUST00000094055.3
ENSMUST00000136328.1 ENSMUST00000126296.1 ENSMUST00000153993.2 |
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr15_-_98918131 | 4.45 |
ENSMUST00000023736.8
|
Lmbr1l
|
limb region 1 like |
chr7_+_16310412 | 4.44 |
ENSMUST00000136781.1
|
Bbc3
|
BCL2 binding component 3 |
chr2_-_176917518 | 4.44 |
ENSMUST00000108931.2
|
Gm14296
|
predicted gene 14296 |
chr15_+_25752860 | 4.42 |
ENSMUST00000022882.5
ENSMUST00000135173.1 |
Myo10
|
myosin X |
chr11_+_4031770 | 4.39 |
ENSMUST00000019512.7
|
Sec14l4
|
SEC14-like 4 (S. cerevisiae) |
chr18_-_3281752 | 4.38 |
ENSMUST00000140332.1
ENSMUST00000147138.1 |
Crem
|
cAMP responsive element modulator |
chr10_-_19907545 | 4.38 |
ENSMUST00000134220.1
|
Pex7
|
peroxisomal biogenesis factor 7 |
chr1_-_180245927 | 4.35 |
ENSMUST00000010753.7
|
Psen2
|
presenilin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
5.6 | 22.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
5.1 | 30.4 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
4.9 | 24.7 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
4.0 | 12.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
3.8 | 15.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.4 | 10.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.2 | 12.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.9 | 8.7 | GO:0034971 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) histone H3-R17 methylation(GO:0034971) |
2.8 | 11.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
2.6 | 7.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.4 | 9.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.4 | 9.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.4 | 14.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.3 | 6.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
2.1 | 19.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
2.1 | 8.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.1 | 10.6 | GO:0006548 | histidine catabolic process(GO:0006548) |
2.1 | 12.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
2.1 | 6.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
2.0 | 8.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.0 | 3.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.0 | 11.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.9 | 18.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.9 | 9.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.9 | 9.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.8 | 5.3 | GO:0090649 | rRNA export from nucleus(GO:0006407) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.8 | 88.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.8 | 3.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.7 | 15.6 | GO:0033227 | dsRNA transport(GO:0033227) |
1.7 | 5.2 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
1.7 | 8.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.6 | 4.9 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
1.5 | 4.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.5 | 25.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.5 | 7.4 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
1.5 | 5.9 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
1.4 | 4.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
1.4 | 5.6 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.4 | 4.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.4 | 4.1 | GO:2000979 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
1.4 | 4.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 6.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.3 | 4.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.3 | 6.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.3 | 5.2 | GO:1990401 | embryonic lung development(GO:1990401) |
1.3 | 3.9 | GO:0021759 | globus pallidus development(GO:0021759) |
1.3 | 3.8 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.2 | 15.9 | GO:0097264 | self proteolysis(GO:0097264) |
1.2 | 6.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 6.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.1 | 4.5 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.1 | 3.3 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
1.1 | 2.2 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
1.0 | 5.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 3.1 | GO:0070268 | cornification(GO:0070268) |
1.0 | 4.1 | GO:0090472 | dibasic protein processing(GO:0090472) |
1.0 | 11.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.0 | 15.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.0 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 5.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
1.0 | 5.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.9 | 13.0 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 11.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.9 | 2.7 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.9 | 1.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.9 | 5.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.9 | 12.6 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 | 3.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.9 | 4.4 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.9 | 2.6 | GO:0016240 | autophagosome docking(GO:0016240) |
0.9 | 9.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.9 | 8.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 9.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 2.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.8 | 13.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 4.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.8 | 1.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.8 | 15.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.8 | 7.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.8 | 7.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.8 | 2.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.8 | 6.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 4.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.7 | 3.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.7 | 2.9 | GO:0002780 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.7 | 2.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 5.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.7 | 2.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.7 | 7.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.7 | 2.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 10.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.7 | 2.1 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.7 | 17.4 | GO:0042640 | anagen(GO:0042640) |
0.7 | 4.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.7 | 2.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.7 | 5.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 2.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.7 | 4.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.7 | 6.7 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.7 | 22.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.7 | 19.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 4.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 2.0 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 2.6 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 1.9 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.6 | 5.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 10.8 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.6 | 4.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 3.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 7.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 3.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 9.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 2.9 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 4.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.6 | 1.7 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.6 | 2.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 9.1 | GO:0051608 | histamine transport(GO:0051608) |
0.6 | 5.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.6 | 1.7 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.6 | 2.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 4.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 4.5 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.6 | 6.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.6 | 1.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 1.7 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 3.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 1.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 2.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 1.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.5 | 5.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 4.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 4.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 6.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.5 | 1.6 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 3.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.5 | 1.5 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.5 | 5.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 1.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 3.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.5 | 3.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 9.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 8.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 3.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 0.5 | GO:1901295 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.5 | 22.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.5 | 12.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.5 | 1.4 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.5 | 1.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 4.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 2.4 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.5 | 1.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.5 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 2.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.5 | 4.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.5 | 2.8 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 1.4 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 4.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 1.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 2.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 3.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 5.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 3.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 1.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.4 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 2.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.4 | 2.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 3.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 2.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 2.0 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.4 | 4.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 6.8 | GO:0072189 | ureter development(GO:0072189) |
0.4 | 3.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 5.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 2.8 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 11.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.4 | 1.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 1.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 3.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 1.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.4 | 2.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 8.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 6.1 | GO:0006956 | complement activation(GO:0006956) |
0.4 | 2.7 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 3.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 2.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.4 | 1.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 8.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.9 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.4 | 3.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 4.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 0.7 | GO:2000670 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 6.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.4 | 4.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 2.8 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 1.4 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.3 | 7.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 0.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 3.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 6.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 3.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 2.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 4.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 3.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 2.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 8.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 3.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 0.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 1.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 1.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.3 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 3.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 2.7 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.5 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.3 | 1.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.3 | 1.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 5.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 3.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 2.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 4.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.3 | 2.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 6.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 12.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 14.1 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 6.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 4.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) pyramidal neuron development(GO:0021860) |
0.3 | 1.3 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 1.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 1.8 | GO:2000124 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 2.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 2.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 2.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.3 | 0.8 | GO:0097274 | urea homeostasis(GO:0097274) |
0.2 | 10.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 4.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.5 | GO:0045414 | interleukin-8 biosynthetic process(GO:0042228) regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.2 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 11.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.6 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 3.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 2.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.6 | GO:0051958 | methotrexate transport(GO:0051958) |
0.2 | 1.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 5.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 8.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.6 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 1.8 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) succinate metabolic process(GO:0006105) |
0.2 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 5.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.9 | GO:0002587 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.2 | 0.7 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.9 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.2 | 1.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 1.5 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.2 | 1.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 2.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 2.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.2 | 0.6 | GO:1990743 | protein sialylation(GO:1990743) |
0.2 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 2.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 3.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 0.4 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 5.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 5.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 6.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.1 | GO:0048318 | protein O-linked glycosylation via serine(GO:0018242) axial mesoderm development(GO:0048318) |
0.2 | 8.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 5.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 3.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 2.3 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 7.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.2 | 3.5 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 41.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 2.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 5.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 2.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.5 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.3 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 0.8 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 1.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 1.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.9 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 2.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 1.3 | GO:2001269 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 0.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 7.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 2.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 3.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 2.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.4 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 0.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 13.6 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.4 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 3.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 1.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 10.4 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.8 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 2.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 5.7 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 5.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 2.7 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 2.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 7.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 2.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.6 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 6.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 2.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.3 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 2.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 1.6 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) cellular response to cold(GO:0070417) positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 6.5 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 2.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 1.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 2.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) astral microtubule organization(GO:0030953) |
0.1 | 1.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.5 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 1.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:2000292 | defecation(GO:0030421) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 2.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.5 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.1 | 1.9 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 1.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 3.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 1.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.5 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 1.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 4.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 1.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 2.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 1.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 1.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 2.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 4.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.4 | GO:0045333 | cellular respiration(GO:0045333) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.4 | GO:0003281 | ventricular septum development(GO:0003281) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 15.0 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.4 | 30.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
2.7 | 21.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.4 | 24.1 | GO:0005579 | membrane attack complex(GO:0005579) |
1.9 | 5.6 | GO:0034657 | GID complex(GO:0034657) |
1.8 | 5.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.7 | 5.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.4 | 4.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.2 | 15.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 44.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.0 | 4.0 | GO:0036019 | endolysosome(GO:0036019) |
1.0 | 4.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.9 | 6.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.1 | GO:0044753 | amphisome(GO:0044753) |
0.7 | 2.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.7 | 3.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 1.8 | GO:0098855 | HCN channel complex(GO:0098855) |
0.6 | 12.9 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 2.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 3.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 11.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 4.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 2.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 6.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 4.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 2.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 5.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 2.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 2.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.4 | 1.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 1.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 1.4 | GO:0044307 | dendritic branch(GO:0044307) |
0.4 | 6.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 4.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.8 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 6.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 4.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 2.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 3.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 0.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 7.7 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.3 | 6.3 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 1.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 3.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 4.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 12.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 4.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 6.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 2.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.2 | 5.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 6.5 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 17.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 4.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |